Association of ABCB6 Polymorphisms and Serum Levels with Susceptibility to Antituberculosis Drug-induced Hepatotoxicity

被引：0
|
作者：
Chen, Ruina [1 ]
Cheng, Jingru [1 ]
Pan, Hongqiu [2 ]
Lu, Lihuan [3 ]
He, Xiaomin [4 ]
Zhang, Meiling [5 ]
Yi, Honggang [1 ]
Tang, Shaowen [1 ]
机构：
[1] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Peoples R China
[2] Jiangsu Univ, Peoples Hosp Zhenjiang 3, Dept TB, Zhenjiang, Peoples R China
[3] Second Peoples Hosp Changshu, Dept TB, Suzhou, Changshu, Peoples R China
[4] Peoples Hosp Taixing, Dept Infect Dis, Taixing, Peoples R China
[5] Jiangsu Univ, Jurong Hosp, Dept Infect Dis, Zhenjiang, Peoples R China
来源：
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES | 2025年 / 34卷 / 01期
基金：
中国国家自然科学基金;
关键词：
antituberculosis drug-induced hepatotoxicity; ATP-binding cassette B6; ABCB6; genetic polymorphisms; case; control study; PROTOPORPHYRIN IX ACCUMULATION; INDUCED LIVER-INJURY; PATHOGENESIS; GUIDELINES;
D O I：
10.15403/jgld-5892
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Background & Aims: The occurrence of anti-tuberculosis drug-induced hepatotoxicity (ATDH) deserves our attention. To explore the role of ATP-binding cassette B6 (ABCB6) polymorphisms and serum levels in the risk of antituberculosis drug-induced hepatotoxicity (ATDH). Methods: A 1:4 matched case-control study was conducted. Four single nucleotide polymorphisms (SNPs) and serum ABCB6 levels were analyzed, and false discovery rate (FDR) was performed to correct for multiple comparison. Results: 224 ATDH cases and 896 controls were included. SNP rs1109867 in ABCB6 gene had a decreased risk of ATDH under dominant models (FDR corrected p-value = 0.027). Furthermore, serum ABCB6 levels at three different times in the ATDH cases were higher than those in the controls. Conclusions: SNP rs1109867 in ABCB6 gene may contribute to the susceptibility to ATDH among patients receiving anti-TB treatment.
引用
收藏
页码：55 / 63
页数：9
相关论文
共 50 条
  • [21] Association of Gene Polymorphisms and Serum Levels of ALAS1 with the Risk of Anti-Tuberculosis Drug-Induced Liver Injury
    Han, Bing
    He, Yiwen
    Zhu, Min
    Zhang, Meiling
    Lu, Lihuan
    Xu, Xiaoyan
    He, Xiaomin
    Yi, Honggang
    Tang, Shaowen
    JOURNAL OF CLINICAL PHARMACOLOGY, 2025, 65 (02) : 197 - 205
  • [22] NR1I2 genetic polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity: A systematic review and meta-analysis
    Yang, Miaomiao
    Qiu, Yunliang
    Jin, Yanyu
    Liu, Wenpei
    Wang, Qingliang
    Yi, Honggang
    Tang, Shaowen
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2020, 8 (06):
  • [23] Incidence and associated risk factors of antituberculosis drug-induced hepatotoxicity among hospitalised patients in Wuhan, China
    Xu, Na
    Yang, Jing Xiang
    Yang, Jian
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2022, 29 (04) : 217 - 221
  • [24] Effect of gene-gene and gene-environment interactions associated with antituberculosis drug-induced hepatotoxicity
    Chamorro, Julian G.
    Castagnino, Jorge P.
    Aidar, Omar
    Musella, Rosa M.
    Frias, Ana
    Visca, Mabel
    Nogueras, Mabel
    Costa, Lucas
    Perez, Alessandro
    Caradonna, Fabio
    de Larranaga, Gabriela F.
    PHARMACOGENETICS AND GENOMICS, 2017, 27 (10) : 363 - 371
  • [25] Update meta-analysis of the CYP2E1 RsaI/PstI and DraI polymorphisms and risk of antituberculosis drug-induced hepatotoxicity: evidence from 26 studies
    Wang, F. -J.
    Wang, Y.
    Niu, T.
    Lu, W. -X.
    Sandford, A. J.
    He, J. -Q.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (03) : 334 - 340
  • [26] SLCO1B1 variants and the risk of antituberculosis drug-induced hepatotoxicity: a systematic review and meta-analysis
    Zhu, Min
    Chen, Xinyu
    Hao, Zhuolu
    He, Yiwen
    Han, Bing
    Tang, Shaowen
    PHARMACOGENOMICS, 2023, 24 (18) : 931 - 942
  • [27] The relationship between metabolic enzyme genetic polymorphisms and anti-tuberculosis drug-induced hepatotoxicity
    Sun, Shu-Feng
    Ren, Qi
    Zheng, Guo-Ying
    Han, Tie-Sheng
    Feng, Fu-Min
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (04): : 4321 - 4329
  • [28] Roles of NR1I3 and NR1H4 polymorphisms in the susceptibility to antituberculosis drug-induced liver injury in China: a case-control study
    Xu, Xiaoyan
    Chen, Ruina
    Lu, Lihuan
    Cheng, Jingru
    He, Xiaomin
    Pan, Hongqiu
    Zhang, Meiling
    Yi, Honggang
    Tang, Shaowen
    FRONTIERS IN GENETICS, 2024, 15
  • [29] Genetic polymorphisms of CYP2E1 and GSTM1 loci and susceptibility to anti-tuberculosis drug-induced hepatotoxicity
    Sharma, S. K.
    Jha, B. K.
    Sharma, A.
    Sreenivas, V.
    Upadhyay, V.
    Jaisinghani, C.
    Singla, R.
    Mishra, H. K.
    Soneja, M.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (05) : 588 - 593
  • [30] Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity
    Singla, Neha
    Gupta, Dheeraj
    Birbian, Niti
    Singh, Jagtar
    TUBERCULOSIS, 2014, 94 (03) : 293 - 298
12345